Filing Details

Accession Number:
0001765581-23-000090
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-15 18:00:22
Reporting Period:
2023-08-11
Accepted Time:
2023-08-15 18:00:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756253 Douglas Mark Smith 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2023-08-11 3,075 $0.00 8,546 No 4 A Direct
Ordinary Shares Disposition 2023-08-14 1,241 $138.16 7,305 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.
  2. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.63 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.